Multiple system atrophy (MSA) is a presumed sporadic neurodegenerative disorder of unknown aetiology, clinically characterised by poorly levodopa responsive parkinsonism and/or cerebellar dysfunction in combination with autonomic failure. 1 We previously identified a family with a typical MSA phenotype in two successive generations. 2 One affected patient of that pedigree, now deceased at age 82, and postmortem examination of the brain revealed findings typical of definite MSA. 3 Severe atrophy of the putamen ( fig 1A) and depigmentation of the substantia nigra and pontine and cerebellar atrophy were found upon macroscopic inspection.
Formalin-fixed, paraffin embedded sections stained with haematoxylin/eosin showed profound neuronal loss and gliosis in the striatum, globus pallidus, substantia nigra pars compacta, pontine nuclei and inferior olivary nuclei, marked Purkinje-cell loss and demyelination of cerebellar white matter. Immunohistochemistry for a-synuclein (SNCA) revealed widespread glial cytoplasmic inclusions (GCIs) most numerous in the basal ganglia (fig 1B), cerebellar white matter (fig 1C) , brainstem and spinal cord, and moderate numbers of GCIs in the frontal white matter and corpus callosum. Only mild Alzheimerrelated pathology with single tau-positive neurofibrillar tangles and neuropil threads in the entorhinal and transentorhinal cortex was detectable, and immunohistochemistry with an antibody against TDP-43 was negative (not shown). Sequencing of the entire coding region of the a-synuclein gene revealed no mutation; further, quantitative PCR of exon 3 and exon 4 showed no increased SNCA dosage (data not shown).
Genetic testing had excluded spinocerebellar ataxia (SCA) types 1-3, 6, 7 and 17 in the presented family. 2 In line with previously published data, we also found no mutation in the SCNA gene or a gene dosage effect in the deceased patient. 4 5 Our findings suggest that the present diagnostic criteria for MSA, which explicitly exclude patients with ''a family history of a similar disorder,'' might have led to an underestimation of familial MSA cases. 1 It may be prudent to take into account the possibility of a hereditary component in MSA and to search for more families along the quest to resolve the aetiology of MSA. Similar to Parkinson disease, genetic analysis of larger families might provide clues to the aetiology of this devastating disease.
